By continuing to use our site, you agree to our Terms of Use and Privacy Policy. You can learn more about how we use cookies by reviewing our Privacy Policy.

I Agree

Intuition will tell the thinking mind where to look next -Jonas Salk

MANAGEMENT

Lumos Pharma is led by an experienced management team with longstanding experience in the development and commercialization of therapies in the rare disease space. Our collective team experience ranges from developing novel therapeutics in-house to successful multi-party collaborations with academia and government scientists to advance innovative therapeutics to rare disease patients.

Rick Hawkins

Chief Executive Officer and Chairman

Rick Hawkins is Chief Executive Officer and Chairman of Lumos Pharma. Previously, Mr. Hawkins founded Pharmaco and as Chairman, President and Chief Executive Officer, he managed the growth of that organization to over 700 employees.…

READ MORE

John C. McKew, PHD

President and Chief Scientific Officer

John McKew is President and Chief Scientific Officer of Lumos Pharma. Dr. McKew has twenty-seven years of experience developing novel therapeutics where he successfully advanced therapies through preclinical and into clinical development. Prior to Lumos…

READ MORE

David B. Karpf, AB, MD

Chief Medical Officer

  David B. Karpf is Chief Medical Officer of Lumos Pharma. Dr. Karpf is an academically trained endocrinologist with over 35 years of expertise in all aspects of clinical endocrinology, including among others growth hormone…

READ MORE

Lori Lawley, CPA

Chief Financial Officer

Lori Lawley is Chief Financial Officer of Lumos Pharma. She brings over ten years of experience and accounting expertise in overseeing financial operations, including over five years of public company senior management experience in biotechnology.…

READ MORE

Aaron Schuchart, MBA

Chief Business Officer

Aaron Schuchart is Chief Business Officer of Lumos Pharma.  Mr. Schuchart has over twenty years of experience in key leadership roles for both large multinationals and small biotech companies, including Amgen, Novartis Diagnostics/Grifols, and Coherus…

READ MORE

Brad Powers, JD

Chief Compliance Officer and General Counsel

Brad Powers is the Chief Compliance Officer and General Counsel of Lumos Pharma. Prior to the merger with Lumos Pharma, he served as General Counsel at NewLink Genetics where he was directly responsible for all…

READ MORE

Chris Bemben, MBA, PMP

Vice President, Business Development

Chris Bemben is Vice President, Business Development of Lumos Pharma. He brings 15 years of business and scientific experience developing novel therapeutics from discovery to late-stage clinical development. As a member of the senior management…

READ MORE

Michael O. Thorner, MB, BS, DSc, FRCP, MACP

Vice President, Endocrine Sciences

Michael Thorner is Vice President, Endocrine Sciences of Lumos Pharma. Dr. Thorner most recently was Chair of the Department of Medicine and preceding that was Chief of the Division of Endocrinology and Metabolism and Director…

READ MORE

Roy Smith, PhD

Scientific Advisor, Endocrine

Dr. Roy Smith is Scientific Advisor, Endocrine Science of Lumos Pharma. He has more than fifty years of academic and industrial research experience focused on drug discovery with over 300 peer-reviewed publications and issued patents.…

READ MORE

Ed Varnado, MBA

Vice President, Finance

Ed Varnado is Vice President, Finance of Lumos Pharma. He brings over twelve years of experience and finance expertise in the biotechnology industry. Prior to joining the Lumos Pharma team, he held various roles of…

READ MORE

BOARD OF DIRECTORS

Rick Hawkins

Chief Executive Officer and Chairman

Rick Hawkins is Chief Executive Officer and Chairman of Lumos Pharma. Previously, Mr. Hawkins founded Pharmaco and as Chairman, President and Chief Executive Officer, he managed the growth of that organization to over 700 employees.…

READ MORE

Thomas A. Raffin

Board Member

Thomas A. Raffin, MD, has served as a member of NewLink Genetics’ Board (now Lumos Pharma) since 1999. Dr. Raffin has spent 30 years on the faculty at Stanford University School of Medicine, where he…

READ MORE

Kevin Lalande

Santé Ventures

Kevin Lalande, MBA, is a Co-Founder and Managing Director of Santé Ventures, a healthcare and life science venture capital firm founded in 2006 which currently manages over $500 million across three funds with 30+ portfolio…

READ MORE

Chad A. Johnson

Board Member

Chad A. Johnson, JD, has served as a member of NewLink Genetics’ Board (now Lumos Pharma) since March 2018. Mr. Johnson is currently Senior Counsel at BASF. From May 2017 to October 2022, Mr. Johnson…

READ MORE

Lota S. Zoth

Board Member

Lota S. Zoth, CPA, has served as a member of NewLink Genetics’ Board (now Lumos Pharma) and Chair of our Audit Committee since November 2012. Ms. Zoth currently also serves on the Board of Directors…

READ MORE

Joe McCracken

Board Member

Dr. McCracken has more than twenty-five years of experience in the pharmaceutical and biotechnology industry. Until his retirement in 2013, he had a successful career in the industry where he held top managerial positions in…

READ MORE

An van Es-Johansson

Board Member

Dr. An van Es-Johansson, M.D. has served as a member of our Board since February 2021.  Dr. van Es-Johansson currently serves as a senior advisor for start up companies. Dr. van Es-Johansson was previously the…

READ MORE

CLINICAL SCIENTIFIC ADVISORY BOARD

Mark Bach

Dr. Bach is a pediatric endocrinologist with 30 years of clinical research and pharmaceutical development experience, including extensive global experience building and leading clinical teams that have successfully launched innovative pharmaceutical products into global markets.…

READ MORE

Peter Clayton

Dr. Clayton has been a Professor of Child Health and Paediatric Endocrinology at the University of Manchester since 2001. He has authored 200 publications on the clinical and basic science aspects of pediatric endocrinology and…

READ MORE

Reiko Horikawa

Dr. Horikawa, a pediatric endocrinologist, is the Director of the Endocrinology and Metabolism Division of the Japanese National Center for Child Health and Development (NCCHD) and has been with the NCCHD since 2002. She is…

READ MORE

Ron Rosenfeld

Dr. Rosenfeld serves as Professor and Chair (emeritus) of Pediatrics, Oregon Health & Science University in addition to his role as President of STAT5, LLC.  The author of over 600 publications and eight-edited books, Rosenfeld…

READ MORE

George Werther

Professor George Werther, a pediatric endocrinologist, is Director of the Centre for Hormone Research at Murdoch Children’s Research Institute and Director of Endocrinology at the Royal Children's Hospital (RCH) in Melbourne. Werther has been involved…

READ MORE